Wyatt Technology Corp. (WTC) is the world's largest company dedicated to light-scattering detectors for LC. Dr. Philip J. Wyatt, the president and founder of the company, was the developer of the first commercial multiangle light-scattering instruments more than 40 years ago.
Company Description
Wyatt Technology Corp. (WTC) is the world's largest company dedicated to light-scattering detectors for LC. Dr. Philip J. Wyatt, the president and founder of the company, was the developer of the first commercial multiangle light-scattering instruments more than 40 years ago. Dr. Wyatt is one of the world's leading authorities in the light-scattering field, holds more than 20 patents pertaining to light scattering, and is the author of four texts and over 50 publications. The company's light-scattering detectors have been sold in more than 50 countries, making them the most popular light-scattering instruments available. Wyatt Technology's extensive applications laboratory coupled with its full-time staff (including 17 Ph.D. scientists) means our customers receive deep technical expertise and support.
Chief Chromatographic Techniques Supported
Markets Served
Wyatt provides its products to a wide range of markets including, but not limited to, companies involved with biotechnology, pharmaceutical development, chemical, petrochemical, and academic research laboratories. In addition, WTC provides its products to the United States government and has active customers in the Food and Drug Administration, National Institutes of Health, and the U.S. Army, Navy, and Air Force. Abroad, WTC's distributor network supplies the world with products, support, and training, be it in Asia, Europe, Africa, or South America.
Major Products/Services
WTC's family of instruments includes:
Facilities
WTC maintains more than 30,000 ft2 of modern electronics, optical prototype, machine shop, and laboratory facilities in Santa Barbara, California.
Wyatt Technology Corp.
6300 Hollister Ave.
Santa Barbara, CA 93117
TELEPHONE
(805) 681-9009
FAX
(805) 681-0123
WEB SITE
NUMBER OF EMPLOYEES
80
YEAR FOUNDED
1982
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.